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Abstract 
Purpose: To develop a simple and selective isocratic method for the determination of venlafaxine and 
modafinil in tablet dosage forms.  
Methods: The compounds were analyzed on Waters symmetry C18 column (4.6 mm x 250 mm i.d, 
5µm) using a mobile phase consisting of a mixture of ammonium acetate buffer (pH was adjusted to 4.0 
with glacial acetic acid):10 % methanol in acetonitrile, in the ratio of 60:40. The flow rate was 1.0 ml/min 
and column effluents were monitored at 225 nm. The method was validated according to ICH 
guidelines. 
Results: Venlafaxine and modafinil were eluted with retention times of 4.416 min and 6.443 min, 
respectively. The method was linear in the range of 1.0 - 50 µg/ml for both venlafaxine and modafinil. 
The relative standard deviation (%RSD) was < 1 for both drugs while mean recovery values at different 
concentration levels were within limits. The performance of the method was not changed when small 
variations in the method were made.  
Conclusion: The proposed method is accurate, reproducible and low-cost, and can be used for the 
routine analysis of the individual drugs in formulations.  
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Venlafaxine is a third-generation, structurally 
novel phenethyl bicyclic antidepressant [1]. 
Venlafaxine inhibits synaptosomal re-uptake of 
both serotonin and noradrenalin, and it is also a 
relatively weak inhibitor of dopamine re-uptake 
[2].  
 
Modafinil, prescribed principally to treat 
narcolepsy, is undergoing assessment for other 
neuropsychiatric disorders and medical 
conditions. The neurochemical substrates of 
modafinil are unresolved. It has been postulated 
that modafinil enhances wakefulness by 
modulating dopamine, norepinephrine, or 
serotonin transporter activities [3].  
 
There are several methods reported for the 
determination of venlafaxine in biological fluids 
[4-7] However, for its determination in drug 
formulations only two methods have been 
reported [8-9].  
 
For determination of modafinil in biological fluids 
[10-14] and formulations [15-16], some methods 
have been reported. The aim of this present 
study is to develop a single method for the 
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determination of venlafaxine and modafinil in 




Materials and equipment 
 
Waters High Performance Liquid 
Chromatographic HPLC system equipped with a 
diode array detector and auto-sampler was used.  
Waters symmetry C18 column (4.6 mm x 250 
mm i.d) was used for separation. 
Chromatographic and integrated data were 
recorded using Empower 2 software. All the 
reagents were of analytical grade unless stated 
otherwise. Milli Q water, HPLC-grade acetonitrile 
(Rankem, Mumbai, India), methanol (Rankem, 
Mumbai, India) and ammonium acetate (AR 
grade, S.D. Fine Chem, Mumbai, India) were 
used. All solutions were filtered through 0.45 µm 
membrane filters procured from Pall Pharma Lab 
Filtration Pvt Ltd (Mumbai, India). 
 
Preparation of standard solutions 
 
Twenty tablets of venlafaxine were accurately 
weighed, ground to powder and powder 
equivalent of 25 mg (1 tablet) of active ingredient 
was taken into a 50 ml volumetric flask, dissolved 
in 35 ml of 50% methanol in water (diluent), ultra 
sonicated for about 10 min, filtered and volume 
made up to the mark with the diluent. From this 
solution, 0.5 ml of solution was transferred to 10 
ml volumetric flask, 5 ml of diluent was added, 
sonicated to mix and volume was made up to 
mark with diluent. 
 
Ten milligrams of modafinil working standard was 
taken into a 10 ml volumetric flask, dissolved in 
4-5 ml of diluent, ultra-sonicated for about 10 
min, filtered and the volume made up to the mark 
with the diluent (Standard Stock). From this 
solution, 0.2 ml of solution was transferred to 10 
ml volumetric flask, 5 ml of diluent was added, 
sonicated to mix and the volume was made up to 
mark with diluent. 
 
Preparation of sample solutions 
 
A working standard of venlafaxine (12.5 mg) was 
taken into a 25 ml volumetric flask, dissolved in 
15 ml of diluent, ultra-sonicated for about 10 min, 
filtered and the volume made up to the mark with 
the diluent (Standard Stock). From this solution, 
0.5 ml of solution was transferred to 10 ml 
volumetric flask, 5 ml of diluent was added, 
sonicated to mix and the volume made up to 
mark with diluent. 
 
Twenty tablets of modafinil were accurately 
weighed, grounded to powder and powder 
equivalent of 200 mg (1 tablet) of active 
ingredient was taken into a 100 ml volumetric 
flask, dissolved in 70 ml of diluent, ultra-
sonicated for about 10 min, filtered and the 
volume made up to the mark with the diluent. 
From this solution, 0.1 ml of solution was 
transferred to a 10 ml volumetric flask, 5 ml of 
diluent was added, sonicated to mix and the 
volume made up to mark with diluent. 
 
Preparation of 0.02 M ammonium acetate 
buffer (pH 4.0) 
 
Ammonium acetate (1.07972 g) was transferred 
to a 1 L volumetric flask. water (700 ml) was 
added and sonicated to dissolve and degas, 
filtered through 0.45µm filter paper and volume 
was made up to the mark with water. The pH of 
the resultant solution was adjusted to 4.0 with 
glacial acetic acid and sonicated for 2 min for 
proper mixing. 
 
Preparation of 10 % methanol in acetonitrile 
 
Methanol (45 ml) was taken in a 500 ml 
measuring cylinder, made up to volume with 





Standard solutions of venlafaxine and modafinil 
were injected six times and chromatograms were 
recorded. Relative standard deviation (% RSD) 
of retention times (Rt) and peak areas were 
calculated. The mean of tailing factor (T. Factor) 





Blank solution (mobile phase), standard 
solutions, sample solutions and placebo solution 
(sample solution but excluding active ingredients) 
were injected separately into the system and 




Six different samples of both drugs were 
analyzed and % RSD of assay values was 
calculated. 
 
Ruggedness (Intermediate precision) 
 
The analysis was performed by a second analyst 
on Schimadzu HPLC system. The assay of six 
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different samples was performed and % RSD of 




Solutions in the concentration range of 1 - 50 





Accuracy of method was measured in terms of % 
recovery. Sample solutions were prepared at 
three different concentration levels, i.e., 80, 100 
and 120 %. A predetermined amount of standard 
was added to these solutions and % recovery 




Slight variations in buffer pH, mobile phase 
composition, column temperature and flow rate 
were carried out and standard solution was 
injected. Six replicates and system suitability 
tests were performed and the validation 




For mobile phase stability, mobile phase was 
prepared and stored in a refrigerator. The 
analysis was performed using freshly prepared 
sample and standard solutions on the first and 
second day. For sample solution stability, sample 
and standard solutions were prepared at 
specification level and stored in a refrigerator. 
The analysis was performed using freshly 





Kromasil C18 column and mobile phase 
containing 0.02M ammonium acetate (pH 4.0), 
10 % methanol in acetonitrile (60:40) were found 
to be suitable for analysis of both venlafaxine 
and modafinil. The other chromatographic 
conditions optimized were flow rate of 1.0 ml/min, 
detection wavelength of 225nm, column 
temperature of 40 oC, injection volume of 20 ml, 
diluent methanol:water (50:50, v/v), and a run 




To check the system and column performance, 
the standard solution was injected six times and 
the following parameters were monitored. 
System suitability results are shown in Table 1. 
Tailing factor was < 1.5 for both venlafaxine and 
modafinil. Theoretical plates were 4500 for 
venlafaxine and 5500 for modafinil. %RSD of 
retention time and peak area was < 1 % for both 
venlafaxine and modafinil. 
 
Table 1: System suitability results 
 
Parameter Venlafaxine Modafinil 
% RSD of retention time 0.35 0.46 
% RSD of peak area 0.61 0.39 
Tailing Factor 1.42 1.13 




The sample and standard chromatograms were 
identical. There were no peaks in both blank and 
placebo chromatograms which shows that there 
was no interference of excipients in the analysis 
of the drugs. Typical chromatograms are shown 
in Fig 1. 
 
Precision and intermediate precision 
 
The %RSD values of venlafaxine and modafinil 
for method precision were 0.71 and 0.58 
respectively but for intermediate precision these 





Venlafaxine and modafinil showed linearity in the 
range 1 - 50 μg/mL, and was represented by the 
following linear regression equations: Y = 
34918X + 1013 (r2=0.9998), Y = 26759X + 3286 




Recoveries of venlafaxine and modafinil were 
between 98.0 and 102.0 %, indicating good 
accuracy of the developed method. The results 




In all cases where deliberate changes were 
made to the procedure, no significant changes 
were observed in the results. %RSD of peak 
area and retention time were < 1 %. The results 




The drug solution and mobile phase were stable 
up to 48 hours in refrigerated condition. There 
was not much change in assay value; the results 
are shown in table no 5.  
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Figure 1: Typical chromatograms 
 





















Parameter Venlafaxine   Modafinil  
 
Precision 
Average 99.83 100.04 
%RSD 0.71 0.58 
Intermediate Precision Average 99.67 99.89 





















80 5.00 4.98 99.60 5.00 4.97 99.40 
100 10.00 9.92 99.20 10.00 9.95 99.50 
120 15.00 14.93 99.53 15.00 14.96 99.73 
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Table 4: Results of robustness 
 
pH variation 3.9 4.0 4.1 
Venlafaxine Modafinil Venlafaxine Modafinil Venlafaxin e Modafinil  
% RSD Rt 0.53 0.41 0.58 0.71 0.65 0.53 
% RSD area 0.61 0.47 0.48 0.66 0.69 0.77 
T. Factor 1.44 1.11 1.49 1.14 1.53 1.08 
T. Plates 4398 5098 4456 5215 4396 5172 
Variation of 
mobile phase  
composition 
65: 35 60:40 55:45 
% RSD Rt 0.38 0.42 0.46 0.62 0.71 0.38 
% RSD area 0.47 0.53 0.34 0.49 0.64 0.47 
T. Factor 1.45 1.09 1.51 1.14 1.63 1.21 
T. Plates 4231 5341 4837 5169 4657 5481 
Temperature 
variation 
35oC 40oC 45oC 
% RSD Rt 0.58 0.64 0.38 0.71 0.44 0.53 
% RSD area 0.71 0.52 0.63 0.46 0.52 0.51 
T. Factor 1.61 1.09 1.44 1.11 1.37 1.15 
T. Plates 4326 5312 4609 5423 4281 5257 
Flow variation 0.8 ml/min 1.0 ml/min 1.2 ml/min 
% RSD Rt 0.45 0.56 0.39 0.41 0.53 0.67 
% RSD area 0.79 0.82 0.53 0.36 0.72 0.61 
T. Factor 1.51 1.21 1.44 1.15 1.48 1.17 
T. Plates 4376 5412 4672 5481 4486 5347 
 
Table 5: Solution and mobile phase stability data 
 
Solutions Stability Assay of Samples % Variation 
Initial 1st day 2nd day 1st day 2nd day 
Venlafaxine 99.12 99.07 98.87 0.05 0.25 
   Modafinil 99.33 99.08 98.67 0.25 0.66 
Mobile phase stability      
Venlafaxine 99.12 98.82 98.75 0.30 0.37 




Venlafaxine and modafinil are structurally close 
and have similar polarities. Both drugs were 
analysed by reverse phase HPLC on commercial 
C18 columns, using 0.05M ammonium acetate 
and 0.01M potassium dihydrogenortho-
phosphate buffers with organic modifiers, viz, 
methanol and acetonitrile. Inertsil C18 did not 
show any selectivity for the compounds. Analysis 
was tried on a Kromasil C18 (4.6 mm x 250 mm 
i.d, 5 µm particle size) column, using 0.05M 
ammonium acetate buffer and methanol as well 
as methanol/acetonitrile in varying proportions. In 
methanol alone, modafinil was not eluted, but 
when acetonitrile was added, modafinil was 
eluted (as acetonitrile content increased) and the 
retention times were high. The compounds were 
analyzed on Waters C18, (4.6 mm x 250 mm i. d, 
5µm), using buffers, methanol and acetonitrile in 
different proportions. The mobile phase 
containing 0.05M ammonium acetate buffer and 
10 % methanol in acetonitrile eluted both 
compounds in less time, with good peak 
symmetric properties. The concentration of the 
organic modifier, buffer pH and column 
temperature were optimized to separate the two 
compounds with good resolution in less time. 
 
For efficient analysis of the compounds, various 
concentrations of acetonitrile were studied. At 
lower concentrations, it took a longer time for 
elution of the compounds. Also, there was a 
slight increase in tailing factor as concentration 
increased.  
 
Studies were carried out on the effect of buffer 
pH on tailing factor and retention times. There 
was a slight increase in tailing of compounds, 
while the retention time for venlafaxine increased 
and resolution decreased as buffer pH increased  
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from 3.0 to 5.0.  At pH 4.0, symmetrical peaks 
with good resolutions were obtained.  
 
The column was maintained at different 
temperatures ranging from 25 to 50 ˚C. Tailing 
was reduced with increasing temperature for 
venlafaxine and a slight increase was observed 
for modafinil. Retention times decreased slightly 
with increasing temperature, but the peaks 
became sharp, and resolution was good for the 
compounds at 40˚C.  
 
Good symmetrical peaks were obtained with the 
mobile phase, 0.05M ammonium acetate (pH 
4.0): 10 % methanol in acetonitrile (60:40 v/v) on 
Waters C18 (4.6 mm x 250 mm) column 
maintained at 40 ˚C. Flow rate was kept at 
1.0ml/min. The UV overlaid spectra of both 
venlafaxine hydrochloride and modafinil showed 
that both drugs absorb appreciably at 225 nm; 
hence, 225 nm was selected as the detection 
wavelength. The retention time of venlafaxine 
hydrochloride was 4.4 min and that of modafinil 
6.3 min. Asymmetric factor for venlafaxine 
hydrochloride was < 1.5 and for modafinil, it was 
< 1.2. 
 
Relative standard deviation (% RSD) of retention 
times (Rt) and peak areas were < 1 and means 
of tailing factor (> 2), resolution factor (> 2) and 
theoretical plates (> 2000) were well within the 
limits, hence the method passed system 
suitability tests. There was no interference of 
excipients with the analysis of the drugs. The 
standard and sample chromatograms were 
identical, which proves that the method is 
specific. The mean amount of drugs was 99.83 
and 100.04 % for modafinil and venlafaxine, 
respectively. When analysis was performed by a 
second analyst on a second system, RSD was < 
1 %, , which proves the precision of the method. 
The method showed good linearity for both 
venlafaxine and modafinil. The method  is robust 
and unaffected by small variations in test 





A simple and accurate reverse phase HPLC 
method has been developed for the 
determination of venlafaxine and modafinil. The 
method was validated as per ICH guideline in 
terms of specificity, precision, accuracy, linearity, 
limit of detection, ruggedness, robustness and 
solutions and mobile phase stability. A single 
method can thus be used for the routine analysis 
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